← Leaderboards
Mei Chen
University Of Southern California
$5,756,985
Attributed
$8,662,343
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,662,343 · 4
By mechanism
R01$4,997,206 · 2
RC4$3,084,337 · 1
R21$580,800 · 1
Top collaborators
- David T Woodley9 shared
Most similar at University Of Southern California
Same institution · by research overlap
- David T Woodley$8,753,993
Others in their field
Top investigators on “Keratinocyte”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Kathleen Janee Green · Northwestern University$26,824,381
- Elaine Fuchs · University Of Chicago$24,033,644
- Gian Paolo Dotto · Massachusetts General Hospital$19,822,465
- Richard L Gallo · University Of California, San Diego$19,668,478
- Pierre Coulombe · Johns Hopkins University$19,316,020
Research focus
KeratinocyteFibroblastsTransplantationSkinPhenotypeStructureLentivirus VectorCellsDermisIn VivoGene CorrectionMutationBullaGenesCollagen Type ViiDermalBaseInheritedProteinsEpidermolysis Bullosa DystrophicaSkin DisorderEpidermisCicatrixVector
Grant awards (18)
A Pilot Study of the Effect of Intravenous Gentamicin on the Restoration of Full-Length Type VII Collagen in RDEB Patients Carrying Nonsense Mutations$290,400
R21 · FY2019 · AR · contact PI
A Pilot Study of the Effect of Intravenous Gentamicin on the Restoration of Full-Length Type VII Collagen in RDEB Patients Carrying Nonsense Mutations$290,400
R21 · FY2018 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$431,080
R01 · FY2012 · AR
Purification of Epidermolysis Bullosa Antigen$431,241
R01 · FY2011 · AR
Protein Therapy for Recessive Dystrophic Epidermolysis Bullosa$3,084,337
RC4 · FY2010 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$435,763
R01 · FY2010 · AR
Purification of Epidermolysis Bullosa Antigen$429,709
R01 · FY2009 · AR
Strategies Towards Gene Therapy for Dystrophic Epidermolysis Bullosa$333,218
R01 · FY2009 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$172,786
R01 · FY2009 · AR
Strategies Towards Gene Therapy for Dystrophic Epidermolysis Bullosa$333,218
R01 · FY2008 · AR · contact PI
Purification of Epidermolysis Bullosa Antigen$245,000
R01 · FY2008 · AR
Strategies Towards Gene Therapy for Dystrophic Epidermolysis Bullosa$340,018
R01 · FY2007 · AR · contact PI
Strategies Towards Gene Therapy for Dystrophic Epidermolysis Bullosa$350,173
R01 · FY2006 · AR · contact PI
Strategies Towards Gene Therapy for Dystrophic Epidermolysis Bullosa$357,500
R01 · FY2005 · AR
Gene Therapy for Dystrophic Epidermolysis Bullosa$284,375
R01 · FY2004 · AR
Gene Therapy for Dystrophic Epidermolysis Bullosa$284,375
R01 · FY2003 · AR
Gene Therapy for Dystrophic Epidermolysis Bullosa$284,375
R01 · FY2002 · AR
Gene Therapy for Dystrophic Epidermolysis Bullosa$284,375
R01 · FY2001 · AR